Fresenius Kabi’s FDA-approved, generic Icatibant Injection provides patients with a new option in treating acute attacks of Hereditary angioedema (HAE). Icatibant Injection is less expensive, easy to use, fully substitutable, and chemically equivalent*.
Icatibant Injection is supplied as a 3 mL prefilled, single use syringe and is available in both single- and three-syringe packages.
Fresenius Kabi contracts with a variety of Specialty Pharmacy Partners to provide access to Icatibant Injection. Please contact KabiCare Patient Support Program for additional information at kabicare.us or call 1-833-KABICARE (1-833-522-4227).
Fresenius Kabi, a global healthcare company, developed KabiCare Patient Support Program to help simplify every step of your journey. Whether you need financial assistance, help understanding insurance benefits, or prescription access and delivery, we provide information and support to keep your treatment on course.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, clinical nutrition, and specialty pharmaceuticals. Our products and programs are designed to help care for critically and chronically ill patients. For more than a century, we’ve delivered innovative therapies that are safe, efficient, and affordable.
Recognized for our proven track record of quality, reliability, and consistency, we produce our medications in 90 state-of-the-art plants around the world. From essential injectable medicines to advanced systems used to maintain and protect the nation’s blood supply, our products are used to help care for critically and chronically ill patients. We’re committed to making sure that patients have accurate and transparent information as new medication options come to market.